| Affiliation: | 1.Nuclear Medicine Service, Ospedale Maggiore, Bologna, Italy.;2.Nuclear Medicine Department, Santa Maria della Misericordia Hospital, Rovigo, Italy.;3.Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain.;4.Nuclear Medicine Department, University of Lyon, Lyon, France.;5.Department of Radiology, University of Southern California, Los Angeles, CA, USA. |
| Abstract: | ![]()
In the present review we reported the value of 18F-fluorodeoxyglucose (FDG) PET/CT in face of uterine cancer, in terms of sensitivity, specificity and accuracy. Moreover, we made a comparison with the other imaging techniques currently used to evacuate these tumors including contrast-enhanced CT, contrast enhanced-MRI and transvaginal ultrasonography. FDG PET/CT has been reported to be of particular value in detecting occult metastatic lesions, in prediction of response to treatment and as a pro-gnostic factor. |
